Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge advises Infracapital on the acquisition of Falbygdens Energi
Mandate

Vinge advises Infracapital on the acquisition of Falbygdens Energi

December 02, 2013

Vinge is advising Infracapital, a leading European infrastructure investor, managed by M&G Investment Management, the European investment management arm of Prudential plc in connection with the acquisition of Falbygdens Energi AB from Göteborg Energi AB.

Falbygdens Energi AB operates primarily within the Swedish municipality of Falköping. The business operations comprise mainly of the production and distribution of district heating and the distribution of electricity in the area. The electricity distribution network comprises 522 kilometres of overhead lines and 1,690 kilometres of underground cables. FEAB also operates a broadband business in the municipality.

Johan Göthberg was the responsible partner together with associates Matthias Pannier, Lisa Antman, Joel Zetterström, Gabriel Westin, Emma Kero Ljungberg and counsel Robert Deli. Partner Thomas Sjöberg and associate Sofia Ekdahl are advising on real estate and environmental questions.

Related

Vinge advises Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun

 Vinge is advising Svenska Handelsfastigheter in connection with the acquisition of the Tallen retail park in Falun from Dalafast. The acquisition comprises four properties with a total of 23,200 square metres of retail space, which together constitute Tallen’s largest retail area.
November 11, 2026

Vinge advises Egetis Therapeutics in connection with ANI Pharmaceuticals’ public cash offer

 On 5 November 2026, ANI Pharmaceuticals, Inc., a U.S. biopharmaceutical company listed on The Nasdaq Global Market, announced a recommended public cash offer to the shareholders of Egetis Therapeutics AB (publ) and to the holder of Egetis’ convertible loan and warrants to tender all shares, the convertible loan and the warrants in Egetis to ANI. The total value of the offer amounts to approximately SEK 5,304 million.
November 10, 2026

Vinge has advised Xspray Pharma in connection with its rights issue

 Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 90 million before transaction costs, with an over-allotment issue of approximately SEK 72 million.
November 09, 2026